Ono Pharmaceutical (OTCMKTS:OPHLY) Shares Up 1% – Time to Buy?

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY)’s stock price traded up 1% during trading on Thursday . The stock traded as high as $5.22 and last traded at $5.21. 8,164 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 19,819 shares. The stock had previously closed at $5.1565.

Ono Pharmaceutical Stock Up 1.0%

The stock has a 50 day moving average price of $4.70 and a two-hundred day moving average price of $4.18.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.

In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.